UMLS. CSP-HL7-ICD9CM-NCI-NDFRT-RXNORM
%
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
G G0 G1 G2 G3 G4 GA GB GC GD GE GF GG GH GI GL GM GN GO GP GQ GR GS GT GU GV GW GX GY GZ G%
GR GR GR6 GRA GRB GRC GRE GRF GRI GRK GRN GRO
selected terms: 294 page 1 of 3

1. GR
[A country in Southern Europe, bordering the Aegean Sea, Ionian Sea, and the Mediterranean Sea, between Albania and Turkey. (NCI) ( NCI )] (UMLS (NCI) C0018226) =Geographic Area ;
51. Grade 3b
(UMLS (NCI) C0585113) =Intellectual Product
2. GR 117289
(UMLS (NCI) C0211676) =Organic Chemical; Pharmacologic Substance ;
52. Grade 3b Follicular Lymphoma
(UMLS (NCI) C1333849) =Neoplastic Process
3. GR 38032F
(UMLS (NCI) C0733434) =Organic Chemical; Pharmacologic Substance
53. Grade 3b Lesion
(UMLS (NCI) C1333850) =Finding
4. GR 63178A
(UMLS (NCI) C0950804) =Organic Chemical; Pharmacologic Substance
54. Grade 3b Malignant Neoplasm
(UMLS (NCI) C1333851) =Neoplastic Process
5. GR 85548A
[The hydrochloride salt form of naratriptan, a sulfonamide with selective serotonin (5-HT) 1 receptor agonistic activity and anti-migraine property. Naratriptan hydrochloride binds selectively and with high affinity to the 5-HT1D and 5-HT1B receptor subtypes. Activation of these 5-HT1D/B receptors located on intracranial blood vessels leads to vasoconstriction and provides relief of migraine headaches. Naratriptan hydrochloride may also exerts its effect by stimulation of 5-HT1D/1B receptors on sensory nerve endings in the trigeminal system thereby decreasing the release of pro-inflammatory neuropeptides. ( NCI )] (UMLS (NCI) C0771993) Naratriptan Hydrochloride;
NARATRIPTAN HYDROCHLORIDE PREPARATION;
N-methyl-3-( 1-methyl-4-piperidinyl)-1H-indole-5-ethanesulfonamide Monohydrochloride;
=Organic Chemical; Pharmacologic Substance ;
=NARATRIPTAN;
=NARATRIPTAN HYDROCHLORIDE 1 MG;
NARATRIPTAN HYDROCHLORIDE 2.5 MG;
55. Grade 4 Clear Cell Renal Cell Carcinoma
(UMLS (NCI) C1333852) Grade 4 Conventional (Clear Cell) Renal Cell Carcinoma;
=Neoplastic Process
6. GR-C507/75
(UMLS (NCI) C0733437) =Organic Chemical; Pharmacologic Substance
56. Grade 4 Lesion
(UMLS (NCI) C1333853) =Finding
7. GR6
[Normally expressed in early fetal development by human GR6 Gene, the function of 149-aa 16-kDa Putative GR6 Protein is unknown. (NCI) ( NCI )] (UMLS (NCI) C1308249) GR6 Protein;
Putative GR6 Protein;
=Amino Acid, Peptide, or Protein; Biologically Active Substance
57. Grade 4 Malignant Neoplasm
(UMLS (NCI) C1333854) =Neoplastic Process
8. graafian follicle
[maturing ovum eccentrically located in a hillock of specialized epithelial cells in the ovary; precursor to the mature ovarian follicle which is ejected during ovulation. ( CSP )] (UMLS (CSP) C0600225) =Body Part, Organ, or Organ Component =Genital System, Female, Ovary;
=Granulosa Cell
58. Grade I Colon Adenocarcinoma
(UMLS (NCI) C1333866) Well Differentiated Colon Adenocarcinoma;
=Neoplastic Process
9. Gracilis
(UMLS (NCI) C0224439) =Body Part, Organ, or Organ Component
59. Grade I Colorectal Adenocarcinoma
(UMLS (NCI) C1333867) Low Grade Colorectal Adenocarcinoma;
Well Differentiated Colorectal Adenocarcinoma =Neoplastic Process
10. GRACILIS MUSC TRANSPLAN
[ ] (UMLS (ICD9CM) C0193219) =Therapeutic or Preventive Procedure
60. Grade I Mucoepidermoid Carcinoma of Salivary Gland
(UMLS (NCI) C0279740) =Neoplastic Process
11. Grade
[A position on a scale of intensity or amount or quality. ( NCI )] (UMLS (NCI) C0441800) =Classification
61. Grade I Neuroendocrine Carcinoma
(UMLS (NCI) C1266147) =Neoplastic Process
12. grade
[A system for classifying cancer cells in terms of how abnormal they appear when examined under a microscope. The objective of a grading system is to provide information about the probable growth rate of the tumor and its tendency to spread. The systems used to grade tumors vary with each type of cancer. Grading plays a role in treatment decisions. ( NCI )] (UMLS (NCI) C0919553) grading;
Histologic Grade;
Histopathologic Grade;
Histopathology Grade;
=Classification ;
62. Grade I Rectal Adenocarcinoma
(UMLS (NCI) C1333870) Well Differentiated Rectal Adenocarcinoma;
=Neoplastic Process
13. Grade 1 Clear Cell Renal Cell Carcinoma
(UMLS (NCI) C1333829) Grade 1 Conventional (Clear Cell) Renal Cell Carcinoma;
=Neoplastic Process ;
63. Grade II Colon Adenocarcinoma
(UMLS (NCI) C1333859) Moderately Differentiated Colon Adenocarcinoma;
=Neoplastic Process
14. Grade 1 Conjunctival Intraepithelial Neoplasia
(UMLS (NCI) C1334421) Grade I Conjunctival Intraepithelial Neoplasia;
Low Grade Conjunctival Intraepithelial Neoplasia;
=Neoplastic Process
64. Grade II Mucoepidermoid Carcinoma of Salivary Gland
(UMLS (NCI) C0279742) =Neoplastic Process
15. Grade 1 Corneal Intraepithelial Neoplasia
(UMLS (NCI) C1334422) Grade I Corneal Intraepithelial Neoplasia;
Low Grade Corneal Intraepithelial Neoplasia;
=Neoplastic Process
65. Grade II Neuroendocrine Carcinoma
(UMLS (NCI) C1333862) =Neoplastic Process
16. Grade 1 Cutaneous Follicular Lymphoma
(UMLS (NCI) C1333830) =Neoplastic Process ;
66. Grade II PIN
(UMLS (NCI) C1333864) Grade II Prostatic Intraepithelial Neoplasia;
=Neoplastic Process
17. Grade 1 Diffuse Follicle Centre Lymphoma
(UMLS (NCI) C1333831) =Neoplastic Process ;
67. Grade II Rectal Adenocarcinoma
(UMLS (NCI) C1333865) Moderately Differentiated Rectal Adenocarcinoma;
=Neoplastic Process
18. Grade 1 Glandular Intraepithelial Neoplasia
(UMLS (NCI) C1334423) Grade I Glandular Intraepithelial Neoplasia;
Low Grade Glandular Intraepithelial Neoplasia;
=Neoplastic Process
68. Grade III Colon Adenocarcinoma
(UMLS (NCI) C1333855) Poorly Differentiated Colon Adenocarcinoma;
=Neoplastic Process
19. Grade 1 Intraepithelial Neoplasia
(UMLS (NCI) C0334058) =Cell or Molecular Dysfunction
69. Grade III Colorectal Adenocarcinoma
(UMLS (NCI) C1333856) Poorly Differentiated Colorectal Adenocarcinoma;
=Neoplastic Process
20. Grade 1 Lesion
(UMLS (NCI) C1333833) =Finding ;
70. Grade III Glandular Intraepithelial Neoplasia
[A high grade intraepithelial neoplasia in which there is marked architectural distortion and crowding of the glands, associated with severe cellular atypia. The neoplastic cells display pleomorphic and hyperchromatic nuclei. ( NCI )] (UMLS (NCI) C1266013) =Neoplastic Process
21. Grade 1 Malignant Neoplasm
(UMLS (NCI) C1333834) =Neoplastic Process ;
71. Grade III Mucoepidermoid Carcinoma of Salivary Gland
(UMLS (NCI) C0279744) =Neoplastic Process
22. Grade 1 Pancreatic Intraepithelial Neoplasia
(UMLS (NCI) C1333869) Grade I Pancreatic Intraepithelial Neoplasia;
=Neoplastic Process
72. Grade III Neuroendocrine Carcinoma
(UMLS (NCI) C1266149) =Neoplastic Process
23. Grade 1 Penile Intraepithelial Neoplasia
(UMLS (NCI) C1334427) Grade I Penile Intraepithelial Neoplasia;
Low Grade Penile Intraepithelial Neoplasia;
=Neoplastic Process
73. Grade III Rectal Adenocarcinoma
(UMLS (NCI) C1333858) Poorly Differentiated Rectal Adenocarcinoma;
=Neoplastic Process
24. Grade 1 PIN
[Prostatic intraepithelial neoplasia characterized by the proliferation of secretory cells with irregular spacing in the ducts and acini. Although some proliferating epithelial cells may contain prominent nucleoli, the cytologic atypia and architectural growth patterns that are seen in the high grade prostatic intraepithelial neoplasia are absent. The presence of low grade prostatic intraepithelial neoplasia in needle biopsy is not a risk factor for the subsequent detection of carcinoma on repeat biopsy.. ( NCI )] (UMLS (NCI) C1168328) Grade 1 Prostatic Intraepithelial Neoplasia;
Grade I PIN;
Grade I Prostatic Intraepithelial Neoplasia;
Low Grade Prostatic Intraepithelial Neoplasia;
Low-Grade Intraepithelial Neoplasia of Prostate;
Low-Grade Intraepithelial Neoplasia of the Prostate;
Low-Grade PIN;
PIN-1;
=Neoplastic Process
74. Grade IV Infratentorial Astrocytic Neoplasm
(UMLS (NCI) C1334184) Grade IV Infratentorial Astrocytic Tumor;
Infratentorial Glioblastoma;
Infratentorial Glioblastoma Multiforme =Neoplastic Process ;
25. Grade 1 Squamous Intraepithelial Neoplasia
(UMLS (NCI) C1302773) Grade I Squamous Intraepithelial Neoplasia;
Low Grade Squamous Intraepithelial Neoplasia;
Low-Grade Squamous Intraepithelial Lesion;
LSIL;
=Neoplastic Process
75. Grade IV Supratentorial Astrocytic Neoplasm
(UMLS (NCI) C1336536) Grade IV Supratentorial Astrocytic Tumor;
Supratentorial Glioblastoma;
Supratentorial Glioblastoma Multiforme =Neoplastic Process ;
26. Grade 1 Vaginal Intraepithelial Neoplasia
(UMLS (NCI) C0349554) =Neoplastic Process
76. Graduate
(UMLS (HL7) C1547183) =Idea or Concept =School type;
27. Grade 1 VIN
(UMLS (NCI) C0495106) =Neoplastic Process ;
77. Graduate or professional Degree complete
[Graduate or professional Degree complete ( HL7V3.0 )] (UMLS (HL7) C1552036) =Idea or Concept =Education Level;
28. Grade 2 Clear Cell Renal Cell Carcinoma
(UMLS (NCI) C1333835) Grade 2 Conventional (Clear Cell) Renal Cell Carcinoma =Neoplastic Process ;
78. Graft
(UMLS (HL7) C1546653) =Intellectual Product =Specimen Source Codes;
29. Grade 2 Cutaneous Follicular Lymphoma
(UMLS (NCI) C1333836) =Neoplastic Process ;
79. graft
[Healthy skin, bone, or other tissue taken from one part of the body and used to replace diseased or injured tissue removed from another part of the body. ( NCI )] (UMLS (NCI) C0332835) =Tissue
30. Grade 2 Diffuse Follicle Centre Lymphoma
(UMLS (NCI) C1333837) =Neoplastic Process ;
80. GRAFT CONJUNC CUL-DE-SAC
[ ] (UMLS (ICD9CM) C0176199) =Therapeutic or Preventive Procedure
31. Grade 2 Glandular Intraepithelial Neoplasia
(UMLS (NCI) C1333861) Grade II Glandular Intraepithelial Neoplasia;
Moderate Glandular Dysplasia =Neoplastic Process
81. Graft of muscle or fascia
[ ] (UMLS (ICD9CM) C0177636) =Therapeutic or Preventive Procedure
32. Grade 2 Infiltrating Breast Carcinoma
(UMLS (NCI) C1333838) Grade 2 Invasive Breast Carcinoma;
Intermediate Combined Histologic Grade Infiltrating Breast Carcinoma;
Moderately Differentiated Infiltrating Breast Carcinoma;
Moderately Differentiated Invasive Breast Carcinoma;
Moderately Favorable Infiltrating Breast Carcinoma =Neoplastic Process ;
82. GRAFT REINFORCE SCLERA
[ ] (UMLS (ICD9CM) C0395450) =Therapeutic or Preventive Procedure
33. Grade 2 Intraepithelial Neoplasia
(UMLS (NCI) C0334059) =Cell or Molecular Dysfunction
83. GRAFT REPAIR ATRIAL DEF
(UMLS (ICD9CM) C1304679) Repair of atrial septal defect with tissue graft =Therapeutic or Preventive Procedure
34. Grade 2 Lesion
(UMLS (NCI) C1333839) =Finding
84. GRAFT REPAIR VENTRIC DEF
[ ] (UMLS (ICD9CM) C0189959) =Therapeutic or Preventive Procedure
35. Grade 2 Malignant Neoplasm
(UMLS (NCI) C1333840) =Neoplastic Process
85. Graft Site, Popliteal
(UMLS (HL7) C1546748) =Intellectual Product =Specimen Source Codes;
36. Grade 2 Nodular Sclerosis Hodgkin Lymphoma
(UMLS (NCI) C0334630) =Neoplastic Process
86. graft versus host disease induction
[An immune response to a person's tumor cells by immune cells present in a donor's transplanted tissue, such as bone marrow or peripheral blood. ( NCI )] (UMLS (NCI) C0281604) =Therapeutic or Preventive Procedure ;
37. Grade 2 Pancreatic Intraepithelial Neoplasia
(UMLS (NCI) C0586364) =Disease or Syndrome
87. Graft Versus Host Disease Prophylaxis/Therapy
(UMLS (NCI) C0278845) =Therapeutic or Preventive Procedure
38. Grade 2 Penile Intraepithelial Neoplasia
(UMLS (NCI) C1333863) Grade II Penile Intraepithelial Neoplasia;
=Neoplastic Process
88. graft versus host reaction
[An immunological attack mounted by a graft against the host because of tissue incompatibility when immunologically competent cells are transplanted to an immunologically incompetent host; the resulting clinical picture is that of GRAFT VS HOST DISEASE. ( MSH )] (UMLS (CSP) C0018134) =Pathologic Function
39. Grade 2 Squamous Intraepithelial Lesion
(UMLS (NCI) C1302798) Grade 2 Squamous Intraepithelial Neoplasia;
Grade II Squamous Intraepithelial Lesion;
Grade II Squamous Intraepithelial Neoplasia =Neoplastic Process
89. Graft vs Host Disease _ Transfusion _ Associated
(UMLS (HL7) C1549012) =Pathologic Function =Transfusion Adverse Reaction;
40. Grade 2 Vaginal Intraepithelial Neoplasia
(UMLS (NCI) C0349555) =Neoplastic Process
90. Graft, Popliteal
(UMLS (HL7) C1546749) =Intellectual Product =Specimen Source Codes;
41. Grade 2 VIN
(UMLS (NCI) C0495107) =Neoplastic Process ;
91. Graft-vs-Leukemia Effect
[an advantageous side-effect of a graft-vs-host reaction in which a leukemia patient is first irradiated to kill residual leukemic cells and is then given a bone marrow graft to replenish the immune system. If cytotoxic T cells are not depleted from the bone marrow graft, these alloreactive T cells can attack the host's cells (graft-vs-host reaction) but can also attack the host's residual leukemic cells, thereby assisting in preventing recurrence of disease. ( NCI )] (UMLS (NCI) C0600554) =Organ or Tissue Function ;
42. Grade 3 Clear Cell Renal Cell Carcinoma
(UMLS (NCI) C1333841) Grade 3 Conventional (Clear Cell) Renal Cell Carcinoma =Neoplastic Process
92. grain
[whole fruit or unhusked seed of cereal grasses cultivated as food. ( CSP )] (UMLS (CSP) C0007757) =Food ;
=food;
=corn;
rice;
Triticum aestivum;
43. Grade 3 Infiltrating Breast Carcinoma
(UMLS (NCI) C1333843) Grade 3 Invasive Breast Carcinoma;
High Combined Histologic Grade Infiltrating Breast Carcinoma;
Poorly Differentiated Infiltrating Breast Carcinoma;
Poorly Differentiated Invasive Breast Carcinoma;
Unfavorable Infiltrating Breast Carcinoma =Neoplastic Process
93. gram negative aerobic rods
[ ] (UMLS (CSP) C1328888) =Bacterium ;
44. Grade 3 Lesion
(UMLS (NCI) C1333844) =Finding
94. gram negative anaerobic rods
[ ] (UMLS (CSP) C1328889) =Bacterium ;
45. Grade 3 Malignant Neoplasm
(UMLS (NCI) C1333845) =Neoplastic Process
95. gram negative bacteria
[bacteria which lose crystal violet stain but are stained pink when treated by Gram's method; see RTs for specific organisms. ( CSP )] (UMLS (CSP) C0018150) =Bacterium =bacteria characteristic;
=Campylobacter;
Francisella tularensis;
46. Grade 3 Pancreatic Intraepithelial Neoplasia
[Stage 0: Tis, N0, M0. Tis: Carcinoma in situ. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th ed.) - 2003 ( NCI )] (UMLS (NCI) C0586365) =Neoplastic Process
96. gram negative facultative rods
[ ] (UMLS (CSP) C1328890) =Bacterium ;
47. Grade 3a
(UMLS (NCI) C0585112) =Intellectual Product
97. gram positive bacteria
[bacteria which retain the crystal violet stain when treated by Gram's method; see RTs for specific organisms. ( CSP )] (UMLS (CSP) C0018154) =Bacterium =bacteria characteristic;
=Listeria
48. Grade 3a Follicular Lymphoma
(UMLS (NCI) C1333846) =Neoplastic Process
98. gram positive non spore forming rods
[A gram-positive, non-spore-forming group of bacteria comprising organisms that have morphological and physiological characteristics in common. ( MSH )] (UMLS (CSP) C0018153) =Bacterium
49. Grade 3a Lesion
(UMLS (NCI) C1333847) =Finding
99. gram positive spore forming rods
[ ] (UMLS (CSP) C1328891) =Bacterium ;
50. Grade 3a Malignant Neoplasm
(UMLS (NCI) C1333848) =Neoplastic Process
100. Gram Staining Method
[This is a method (named after the Danish bacteriologist, Hans Christian Gram) for staining and identifying bacteria. It is based on the differential retention of a crystal violet-iodine complex within the cell membrane. Gram-positive organisms will appear blue-black or purple while Gram-negative organisms will appear red. ( NCI )] (UMLS (NCI) C0200966) =Laboratory Procedure

Buy website

Medical Clinic. Optician. Pharmacy. Physician. Travel Agency. Hotel reservation. Child Care. Education. Teachers. Lessons. Tests and Exams. Certification. Shopping Center. Store. Real Estate.
Affordable prices from $100.


 home Dictionaries Armenian-English English-Armenian MeSH Feedback  top
© 2008 -2011 Administrator MEDINDEX.AM